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Edited by Robert BaroukiAbstract We explored a role for the capsaicin receptor, tran-
sient receptor potential channel vanilloid type 1 (TRPV1), in
the regulation of feeding and body mass. On a 4.5% fat diet,
wild-type and TRPV1-null mice gained equivalent body mass.
On an 11% fat diet, however, TRPV1-null mice gained signiﬁ-
cantly less mass and adiposity; at 44 weeks the mean body
weights of wild-type and TRPV1-null mice were 51 and 34 g,
respectively. Both groups of mice consumed equivalent energy
and absorbed similar amounts of lipids. TRPV1-null mice, how-
ever, exhibited a signiﬁcantly greater thermogenic capacity.
Interestingly, we found that 3T3-L1 preadipocytes expressed
functional calcitonin gene-related peptide receptors. Thus, these
data support a potential neurogenic mechanism by which
TRPV1-sensitive sensory nerves may regulate energy and fat
metabolism.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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The capsaicin receptor, transient receptor potential channel
vanilloid type 1 (TRPV1), is an ion channel expressed predom-
inantly in sensory nerves. TRPV1 detects a variety of noxious
physical and chemical stimuli including capsaicin, the pungent
component of chilli-peppers [1,2]. Numerous studies support a
fundamental role for TRPV1 in pain signaling; disruption of
the TRPV1 gene [3,4] and TRPV1 antagonists [5] markedly
attenuate thermal hyperalgesia. Interestingly, there is emerging
evidence for the participation of TRPV1 and capsaicin signal-
ing in other physiologic functions, including the regulation of
feeding and body weight [6]. Dietary administration of capsa-
icin and other chemically-related ‘‘vanilloid’’ compounds can
reduce food intake and increase energy expenditure in animals
and humans [7–10]. Vanilloids exert both short and long-term
eﬀects. Acutely, capsaicin can reduce food intake, an eﬀect that
may be related to altered satiety [7], or alternatively, via vis-
ceral malaise and anorexia [11]. In addition, capsaicin can
stimulate secretion of catecholamines producing a transient in-
crease in metabolism [12]. Chronic administration of vanilloidsAbbreviations: CGRP, calcitonin gene-related peptide; TRPV1, tran-
sient receptor potential channel vanilloid type 1; CRLR, calcitonin
receptor-like receptor
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doi:10.1016/j.febslet.2008.05.021reduces weight gain, adiposity and triglycerides in animals con-
suming high-fat diets [8,13]. Interestingly, chemical destruction
of capsaicin-sensitive neurons in neonates also aﬀords protec-
tion from diet-induced obesity [14,15]. The precise role of
TRPV1 in these eﬀects is unclear. Vanilloids exert complex
pharmacological eﬀects at TRPV1, producing an initial activa-
tion followed by a long-lasting desensitization of the channel
[1,2]. In addition, capsaicin may signal independently of
TRPV1 [16,17]. Further, capsaicin treatment in neonates ab-
lates entire sensory nerves and therefore does not selectively
target TRPV1. To better understand the role of TRPV1 we ex-
plored the eﬀects of a higher-fat diet in wild-type and TRPV1-
null animals. Our data reveal that disruption of the TRPV1
gene protects against diet-induced obesity. Further, we show
that preadipocytes are sensitive to calcitonin gene-related pep-
tide (CGRP), thus revealing a potential neurogenic mechanism
by which TRPV1-expressing neurons may regulate adipocyte
function.2. Materials and methods
2.1. Body weight and feeding studies
All experimental procedures involving animals were approved by the
Georgetown University Animal Care and Use Committee and conform
to NIH guidelines. C57BL6 wild-type and TRPV1-null mice were
house either individually or in a group. Body mass was monitored
from 3 to 44 weeks of age while consuming either a 4.5% fat diet (Puri-
na diet 5001; 23.0% protein, 4.5% fat, 5.3% crude ﬁber, 49% carbohy-
drate, 3.04 kcal/g metabolizable energy, 12.1% of calories provided by
fat) or an 11% fat diet (Purina diet 5015; 17.0% protein, 11.0% fat,
3.0% crude ﬁber, 53.5% carbohydrate, 3.73 kcal/g metabolizable en-
ergy, 25.8% of calories provided by fat). For paired-feeding studies
male WT and TRPV1-null mice were housed individually. TRPV1-null
mice received food ad libitum while WT mice were restricted to the
amount of food consumed by their TRPV1-null counterpart. Both
mice received water ad libitum.2.2. Body temperature
Body temperatures were measured in 9.5 week old mice with a rectal
thermometer inserted 1.8 cm before and 1 h after exposure to 0–2 C.
2.3. RT-PCR
Total cellular RNA was extracted using TRIzol (Invitrogen) accord-
ing to the manufacturers instructions. First strand cDNA synthesis
was performed using SuperScript III Reverse Transcriptase (Invitro-
gen) with the supplied oligo (dT)20 primer. Ampliﬁcation of CRLR
was performed using Platinum Blue PCR Super Mix (Invitrogen) with
the following conditions: denaturation at 94 C for 30 s, annealing at
54 C for 45 s, and extension at 72 C for 30 s for a total of 30 cycles;
and primers: CRLR, forward 5 0-GTTGCCAACGGATCACATTGC-
3 0 and reverse 5 0-ACAAAGCAGCACAAATCGGACC-3 0; b-actin,
forward 5 0-GCTGGTCGTCGACAACGGCT-30 and reverse 5 0-CAG-
GTCCAGACGCAGGGGGCATGG-3 0. Real-time ampliﬁcations
were performed using the ABI Prism 7900HT Sequence Detectionblished by Elsevier B.V. All rights reserved.
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plied Biosystems). RNA was extracted from white and brown adipose
tissues and skeletal muscle (quadriceps containing both fast-glycolytic
ﬁbres – vastus and oxidative ﬁbres – rectus femoris). Oligonucleotide
primers for mouse UCP1, UCP2, and UCP3 were the same as those
previously published [8]. b-Actin was ampliﬁed in parallel reactions
as an endogenous control. The ampliﬁcation proﬁle included denatur-
ation at 95 C for 30 s, annealing at 55 C for 30 s, and extension at
72 C for 30 s for a total of 40 cycles. Dissociation curve analysis
was performed at the end of each real-time PCR run to ensure that pri-
mer dimers were not present. Additionally, the real-time PCR products
were veriﬁed on agarose gel. The comparative threshold cycle (CT)
method was use to determine the relative quantiﬁcation of target
RNA. The target threshold cycle number was normalized to an endog-
enous reference (GAPDH), and relative amounts of UCP message
were normalized to b-actin.
2.4. Lipolysis in vitro and glycerol analysis
Lipolysis was assessed in adipose explants using methods previously
described [18]. Approximately, 100 mg explants of mouse gonadal adi-
pose tissues were minced and placed into a microtube containing 500 ll
Hanks buﬀer. Aliquots were removed at 0 and 5 h. Glycerol release
and plasma glycerol were measured using a glycerol assay kit (Cayman
Chemical Co., Ann Arbor, MI).
2.5. Fat absorption
Fat absorption was measured using methods previously described
[19]. Wild-type and TRPV1-null mice were fed a diet containingFig. 1. TRPV1-null mice gain less body mass than wild-type mice on a high-
male mice consuming either a low-fat (4.5%) or high-fat (11%) diet from 3 to
4.5% fat to an 11% fat diet at 22 weeks of age. (D) Representative photograp
age. (E) Mean body mass of male (age 34 wks: WT n = 11, TRPV1-null n = 7
n = 4 for both) mice consuming an 11% fat diet. t-test *P < 0.05, **P < 0.01,(wt%) 16 fat, 45 non-fat dry milk, and 39 sucrose (30:15:55 fat:pro-
tein:carbohydrate energy%). The fat component was a mixture of
95% saﬄower oil and 5% sucrose octabehenate, a non-absorbable lipo-
philic marker. Fecal samples from the third day were analyzed by GC
for fatty acids.2.6. Calcium imaging
Mouse 3T3-LI preadipocytes were cultured in Dulbeccos Modiﬁed
Eagles Medium with 10% bovine calf serum. Cells were loaded with
1 lM Fluo 4-AM (Molecular Probes, Eugene, OR) for 20 min and
washed for a further 10–20 min prior to recording. The dye was excited
at 480 ± 15 nm. Emitted ﬂuorescence was ﬁltered with a 535 ± 20 nm
bandpass ﬁlter, captured by a SPOT RT digital camera (Diagnostic
Instruments, Sterling Heights, MI) and read into a computer. Analysis
was performed oﬄine using Simple PCI software (Compix Inc., PA).
Drugs were applied via a micropipette (5–10 lm diameter) positioned
at a distance of 100 lm from the cell of interest.2.7. Chemicals
Capsaicin was obtained from Tocris Cookson (Ellisville, MO, USA)
and prepared as a stock solution in ethanol. CGRP was obtained from
Phoenix Pharmaceuticals Inc. (Burlingame, CA, USA) and prepared as
a stock solution in water. Drugs were diluted into physiological solu-
tion prior to experiments.fat diet. (A and B) Mean body mass of wild-type (WT) or TRPV1-null
25 weeks of age (n = 5 for both). (C) Male mice (n = 5) switched from a
h of male WT and TRPV1-null mice on an 11% fat diet at 44 weeks of
and age 44 wks: WT n = 4, TRPV1-null n = 5) and female (age 40 wks:
***P < 0.001.
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3.1. TRPV1-null mice have reduced body mass and adiposity on
a higher-fat diet
We explored changes in body mass of wild-type (WT) and
TRPV1-null mice consuming either a low-fat (4.5%) or high-
er-fat (11%) diet. When placed on a low-fat diet, both groups
exhibited a similar weight gain from 3 to 25 weeks of age
(Fig. 1A). In contrast, when placed on a higher fat diet wild-
type mice gained greater body mass with signiﬁcant diﬀerences
beginning at 17 weeks of age (Fig. 1B). At 44 weeks, the
mean body mass of WT and TRPV1-null male mice was
51 g and 34 g, respectively (Fig. 1D and E). A similar dif-
ference was noted in female mice; with a mean body mass of
47 g and 31 g, respectively (Fig. 1E) at 40 weeks. We also ob-
served diﬀerential weight gain when adult mice raised on a
low-fat diet were switched to a higher-fat diet (Fig. 1C). WT
mice gained signiﬁcantly greater mass compared with
TRPV1-null mice within a 6 week period.
Fig. 2A and B shows that this increase in body mass was
associated with greater adiposity. WT animals raised on an
11% fat diet (28 weeks) had signiﬁcantly greater abdominal
and subcutaneous fat than their TRPV1-null counterparts
(Fig. 2A and B). In addition, adipose tissue from WT mice
had markedly larger adipocytes (Fig. 2C). Furthermore, both
the fat content of the liver and the size of lipid droplets were
greater in WT compared with TRPV1-null animals (Fig. 2C
and D).Fig. 2. TRPV1-null mice have reduced adiposity. (A) Representative photog
adipose tissue from the abdominal cavity and subcutaneous fat in WT an
Representative cross-sections of gonadal adipose tissue (hematoxylin and eo
scale bar indicates 10 lm) from WT and TRPV1-null mice on a high-fat diet.
TRPV1-null mice; ***P < 0.001 t-test).3.2. Wild-type and TRPV1-null mice consume equivalent energy
but possess diﬀerent thermogenic capacities
To test whether food intake accounted for diﬀerences in
body mass and adiposity we monitored cumulative energy in-
take. Fig. 3A shows that WT and TRPV1-null animals con-
sumed equivalent energy on low-fat and high-fat diets. To
conﬁrm this result we performed paired-feeding experiments
in which WT mice consuming high-fat chow were restricted
to the food intake of TRPV1-null counterparts. Fig. 3B shows
that WT mice still gained signiﬁcant body mass on this regi-
men. Thus, these data rule out diﬀerences in energy intake be-
tween WT and TRPV1-null animals. Further, to test for
diﬀerences in intestinal fat absorption we performed fecal fat
analysis. Fig. 3C shows that both WT and TRPV1-null ani-
mals absorbed 98% of dietary fats.
Next, we tested for diﬀerences in energy expenditure. Previ-
ous studies have found that obese mice have a reduced thermo-
genic capacity compared with lean animals and this is reﬂected
by an impaired ability to maintain body temperature in a cold
environment [20]. We therefore measured core body tempera-
tures before and after a 1 h cold exposure (0–2C) in mice
fed either a low-fat or high-fat diet. Fig. 3D shows that cold
exposure produced a 2 C drop in rectal temperature in WT
mice fed a low-fat diet (n = 8, P < 0.01). A signiﬁcantly greater
decrease of 3.4 C, was seen in WT animals consuming a high-
fat diet (n = 6, P < 0.01). In addition, WT mice consuming a
high-fat diet had a lower resting body temperature compared
with animals consuming a low-fat diet (P < 0.01). In contrast,raphs of visceral fat in female WT and TRPV1-null mice. (B) Mass of
d TRPV1-null mice on an 11% fat diet (n = 3, *P < 0.05 t-test). (C)
sin staining, scale bar indicates 200 lm) and liver (Oil Red-O staining,
(D) Mean area of hepatocyte lipid droplets (n = 300 from 3 WT and 3
Fig. 3. Wild-type and TRPV1-null mice have the same food intake and intestinal fat absorption but diﬀerent energy expenditure. (A) Cumulative
energy intake of male mice on a 4.5% fat or 11% fat diet for 8 days (n = 4). (B) Mean gain in body mass for WT and TRPV1-null mice after 7 weeks of
paired feeding (n = 3; *P < 0.05, **P < 0.01 t-test). (C) Total fat absorption by WT and TRPV1-null mice (n = 3). (D) Mean body temperatures of
WT (left) and TRPV1-null (right) mice at room temperature (RT) and after one hour at 0–2 C (Cold) while consuming either the low-fat (4.5% fat)
or high-fat (11% fat) diet (WT: 4.5% fat n = 7, 11% fat n = 6, **P < 0.01 ANOVA; TRPV1-null: 4.5% fat n = 7, 11% fat n = 3, NS by ANOVA).
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ature in TRPV1-null mice consuming either diet (Fig. 3D,
n = 3–7). Aside from an attenuated fever response, TRPV1-
null mice display normal thermoregulation [21]. These data
suggest that TRPV1-null animals have a greater capacity for
thermogenesis than WT animals, and a higher resting meta-
bolic rate when consuming a high-fat diet.
Altered thermogenesis may reﬂect the activity of uncoupling
proteins, particularly in brown fat. Indeed, mice fed a capsai-
cin-rich diet exhibit increased mRNA levels for several uncou-
pling proteins [8]. However, we observed no diﬀerences in
mRNA expression of uncoupling proteins (UCP1-3) in brown
and white adipose tissue, and skeletal muscle of WT and
TRPV1-null mice fed a high-fat diet (data not shown). Fur-
ther, both the plasma glycerol levels (WT 25.6 ± 1.6 mg/dL;
TRPV1-null 25.2 ± 3.2 mg/dL, n = 7–9) and in vitro lipolytic
capacity (WT, 0.36 ± 0.07 mg glycerol g1 h1; TRPV1-null
0.37 ± 0.09 mg glycerol g1 h1, n = 4) were identical in both
sets of animals.
3.3. Adipocytes express functional CGRP receptors
TRPV1 is predominantly expressed on sensory nerve termi-
nals. In turn, these nerves release the neuropeptides, substance
P (SP) and calcitonin gene-related peptide (CGRP). Therefore,
we explored whether TRPV1 could exert an action on prea-
dipocyte function through neurogenic mechanisms. Fig. 4A
shows that CGRP (50 nM) elicited Ca2+ transients in a subset
of 3T3-L1 preadipocytes (30%, 27 of 89 cells), consistent with
activation of an inositol trisphosphate signalling pathway. RT-
PCR conﬁrmed expression of the CGRP receptor, calcitoninreceptor-like receptor (CRLR) (Fig. 4B). In contrast, SP
(50 nM) failed to evoke Ca2+ transients (data not shown,
n = 50). Interestingly, a recent study has described expression
of TRPV1 in 3T3-L1 preadipocytes [22]. However we found
that the TRPV1 ligand, capsaicin (10 lM), failed to evoke
Ca2+ responses (n = 64) whereas all cells responded robustly
to application of 2 mM extracellular ATP (Fig. 4C and D).4. Discussion
These results reveal a novel role for TRPV1 and sensory
nerves in the regulation of obesity. We show that TRPV1-deﬁ-
cient mice are resistant to diet-induced increases in body mass
and adiposity. The phenotype of these knock-out animals clo-
sely matches that of animals following chemical destruction of
sensory aﬀerent neurons [14,15]. Our data therefore suggest
that TRPV1 is the key target of these sensory nerve lesions.
Interestingly, animals that chronically consume dietary vanil-
loids are also protected from diet-induced obesity [8,13]. Vanil-
loids produce an initial activation followed by long-term
desensitization of TRPV1, suggesting that their pharmacolog-
ical eﬀect may be mediated through inhibition of TRPV1. On
the other hand, the possibility that vanilloids signal indepen-
dently of TRPV1 cannot be excluded [16,17]. Thus, three sep-
arate methods of manipulating TRPV1: selective disruption of
the TRPV1 gene, destruction of TRPV1-expressing sensory
neurons and pharmacological activation/desensitization of
TRPV1 produce equivalent eﬀects on body mass and adipos-
ity. Taken together, these data suggest that TRPV1 signalling
Fig. 4. Mouse 3T3-L1 preadipocytes express functional CGRP receptors. (A) CGRP (50 nM) produced Ca2+ transients in 3T3-L1 preadipocytes. (B)
Adipocytes express mRNA for the CGRP receptor, CRLR. (C and D) Capsaicin (10 lM) failed to produce Ca2+ transients in adipocytes, though
cells responded to ATP (2 mM).
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therefore protective.
We found that both WT and TRPV1-null animals exhibited
equivalent energy intake. Further, intestinal absorption of fat
was identical in both groups and this agrees with earlier ﬁnd-
ings that lipid absorption is unaﬀected in animals [13] or hu-
mans [10] treated chronically with capsaicin, which elicits a
functional loss of TRPV1. These data suggest that altered en-
ergy utilization likely accounts for the diﬀerential weight gain.
Consistent with this hypothesis, we found that WT mice have a
reduced thermogenic capacity compared to TRPV1-null coun-
terparts and this eﬀect was more marked on a higher-fat diet.
Resting body temperature was also lower in WT animals con-
suming a high-fat compared with a low-fat diet. This is consis-
tent with a diet-induced reduction in metabolic rate. Obese
strains of mice are known to have decreased thermogenesis
and a lower resting body temperature [20]. Interestingly,
TRPV1-null animals exhibit normal locomotor activity [23]
suggesting that this factor per se does not account for altered
energy utilization.
The precise molecular mechanism by which TRPV1 inﬂu-
ences energy and lipid handling is unclear. One potential path-
way is through insulin signalling. Activation of TRPV1 in
sensory nerve terminals triggers the secretion of CGRP and
SP, two neuropeptides known to modulate pancreatic islet
function [24,25]. Notably, elevated levels of CGRP contribute
to insulin resistance [26]. Indeed, C57/Bl6 mice are prone to
age-onset diabetes and obesity and TRPV1-null animals onthis background are reported to have increased glucose toler-
ance and insulin sensitivity [25]. In this context, it is interesting
that we only observed diﬀerences in body mass in mice older
than 15 weeks. Similarly, altered weight and adiposity in cap-
saicin-desensitized rats is only seen after 14 weeks of age [14].
These data support a role for TRPV1 in age-onset obesity. Sec-
ond, TRPV1 could directly regulate adipocyte function. Pre-
adipocytes are reported to express TRPV1 [22] and treatment
with capsaicin blocks the diﬀerentiation of these cells into ma-
ture adipocytes [17,22]. However, whether capsaicin modulates
adipocyte function via TRPV1 is uncertain. Capsaicin can in-
hibit NF-kappa B and modulate adipocyte function indepen-
dently of TRPV1 [16,17]. Moreover, we could not conﬁrm
functional TRPV1 signaling in mouse 3T3-L1 preadipocytes;
these cells failed to produce elevations in [Ca2+] in response
to capsaicin. Third, our data point to a potential neurogenic
pathway by which TRPV1 may regulate adipocyte function.
TRPV1 triggers the release of neuropeptides from sensory
nerve terminals that are known to innervate fatty tissues. We
found that 3T3-L1 preadipocytes exhibit functional responses
to CGRP and express the CGRP receptor, CRLR. Interest-
ingly, levels of CGRP are elevated in obese humans and ani-
mals [26,27]. Thus, it will be important to explore whether
CGRP can promote obesity through direct modulation of adi-
pocytes.
In summary, our data reveal a role for TRPV1 in promoting
fat accumulation and weight gain. Pharmacologic inhibitors of
TRPV1 are currently under development for pain treatment.
2262 A.L. Motter, G.P. Ahern / FEBS Letters 582 (2008) 2257–2262Our data suggest that TRPV1 antagonists or agonists that pro-
mote TRPV1 desensitization, may have additional utility in the
treatment for obesity.
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